1. Newsroom
  2. Benefiting from trends in thematic investing
Menu
Insight 04.03.2021

Benefiting from trends in thematic investing

Benefiting from trends in thematic investing

At UBP, thematic investing means devising investment strategies that benefit from megatrends, such as the disruptive forces that are reshaping our economy and our society.


The key for us is to understand the implications of these secular trends for individual businesses and identify the investable opportunities that arise from these developments.

One concrete illustration is the well-known rise of the technology sector. In our understanding this is an unstoppable trend, led by the digitalisation of our world, that has a direct effect on traditional sectors outside technology, such as healthcare and consumer products. As a consequence, new “winners” are emerging, and it is our goal to identify these early and invest in them in order to gain exposure to the leaders of tomorrow.

“A thematic investment portfolio aims to capture returns that are not available to passive index-tracking investors by picking companies across sectors that are in the sweet spot for benefiting from future growth opportunities.” 

Diane Berkovits

For instance, e-commerce platforms and payments processing companies operate in different sectors of the economy but have much in common: they are innovative and profit from the shift from high street shopping to e-commerce. The addressable market is substantial and growing, as are potential returns. 

If the structural trend is well identified, it is likely to last throughout short-term economic cycles, making for a resilient investment over time. This also helps reduce risks by avoiding potential laggards that are about to be disintermediated.

How we do it 

The first question we ask ourselves when we implement a thematic investment idea is, how valid is this theme in the long term? Of course, answering this question is more art than science. Nevertheless, we can identify a few patterns associated with valid investment themes, such as technological innovation, a change in consumer behaviour and regulatory pressure. What’s most important for us is having the relevant in-house expertise to make these judgements. Expertise is not something that we outsource. Over time, we have built up a team of investment specialists that are experts of their sector and conduct true bottom-up fundamental research. 

What we seek is pure exposure to our investment themes, which often means looking at small, specialised companies as opposed to large blue-chip names that tend to be too diversified. 

“Operationally, our high-conviction themes have to be straightforward to trade, therefore we typically wrap them into in-house certificates with daily liquidity. We manage these certificates actively, since each theme is bound to evolve over time, so stock selection needs to be dynamic.” 

Philippe Henry

Our thematic offering

At UBP, we have been actively developing thematic investment solutions since 2017. So far, we have launched seven thematic equity baskets that reflect three major megatrends shaping the world: innovation, resources, people.

Our Artificial Intelligence certificate has been built around the belief that data is the world’s new oil; the new Consumer certificate is linked to shifting consumer preferences; and the Medical Innovation certificate focuses on innovation in the healthcare sector such as therapeutic innovations and technological innovations like telemedicine.

The ageing of the world’s population is a long-term trend that acts as an accelerator for structural change in the world. In this vein, last year we launched a certificate that selects the leaders of tomorrow in a post-Covid world. More recently, we have designed a Global Recovery certificate that benefits from companies with unrealised recovery potential as well as leading innovative industrial companies that are bound to benefit from the ongoing energy transition.

Discretionary Portfolio Management

Note: The products or services mentioned are provided as general information only and are not intended to provide investment or other advice. Not all products or services described are available in all jurisdictions. Past performance is not a guarantee of future results. For the full disclaimer, please refer to Legal Aspects.


Berkovitz_Diane_150x150.jpg
Diane Berkovits
Senior Portfolio Manager
Go to her Linkedin profile.

Henry_Philippe_150x150.jpg
Philippe Henry
Global Head of Advisory Services
Go to his Linkedin profile.

Expertise

Agility: at the heart of our discretionary management

Your goals and aspirations are unique – so is our approach to discretionary portfolio management.

Read more
Expertise

Swiss & Global Equities

Why Swiss equities now? This market offers equity investors the stability and agility they need to navigate this volatile period. 

Read more
Expertise

European Equities

European equities offer unrivalled opportunities in terms of breadth of sector and market exposure.

Read more

Most read

Insight 10.02.2021

COVID-19: UBP keeps you up to date

Since this coronavirus appeared, UBP has provided its clients with guidance and support as we all tackle this unprecedented global health crisis. We give you regular updates on everything from our own safety protocols and the recommendations issued by the authorities to our experts’ latest analysis on the effects of the pandemic on the world economy and financial markets.

Insight 17.12.2020

UBP Investment Outlook 2021

A Brave New World

Insight 24.11.2020

Hidden gems in Swiss & European small caps

Small and mid caps have traditionally recorded higher growth rates and investment returns over the long term than large caps: it is easier to generate a dynamic growth rate from a smaller base. Swiss and European small and medium-sized capitalisations – so-called ‘SMID caps’ – also tend to provide investors with ‘pure play’ exposure to major secular growth trends.


Further reading

Insight 14.04.2021

The vaccine disrupting the pharma industry

UBP talks to Stéphane Bancel, Moderna CEO, to learn how the mRNA technology not only made one of the first COVID-19 vaccines possible, but, more importantly for investors, has the potential to disrupt the broader pharmaceutical industry in its wake.

Insight 05.04.2021

Transitioning to a Brave New World

Volatility is back in Chinese equity markets: after rallying 90% from its trough in March 2020 to a peak in February 2021, MSCI China has fallen by 16% over the past month.

Insight 24.03.2021

Agility: at the heart of our discretionary management

Your goals and aspirations are unique – so is our approach to discretionary portfolio management.